Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinic

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.11, 2000-11, pp. : 1711-1724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotides As Therapeutic Agents

By Alama A. Barbieri F. Cagnoli M. Schettini G.

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-01 ,pp. : 463-470

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Human Telomerase by Antisense Oligonucleotides and Ribozymes: An Update

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 4, 2004-10 ,pp. : 413-417

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides

Current Drug Targets, Vol. 2, Iss. 2, 2001-06 ,pp. : 167-180

Bentham Science Publishers

Access to resources Recommend Favorite

Chemosensitization by Antisense Oligonucleotides Targeting MDM2

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-01 ,pp. : 51-56

Bentham Science Publishers

Access to resources Recommend Favorite